MenAfriVac
MenAfriVac is a vaccine developed for use in sub-Saharan Africa for children and adults between 9 months and 29 years of age against meningococcal bacterium Neisseria meningitidis group A. The vaccine costs less than US$0.50 per dose.
Link from a Wikipage to another Wikipage
primaryTopic
MenAfriVac
MenAfriVac is a vaccine developed for use in sub-Saharan Africa for children and adults between 9 months and 29 years of age against meningococcal bacterium Neisseria meningitidis group A. The vaccine costs less than US$0.50 per dose.
has abstract
MenAfriVac est un vaccin contr ...... r le Serum Institute of India.
@fr
MenAfriVac is a vaccine develo ...... ts less than US$0.50 per dose.
@en
Wikipage page ID
29,735,583
page length (characters) of wiki page
Wikipage revision ID
1,018,407,454
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
hypernym
type
comment
MenAfriVac est un vaccin contr ...... r le Serum Institute of India.
@fr
MenAfriVac is a vaccine develo ...... ts less than US$0.50 per dose.
@en
label
MenAfriVac
@en
MenAfriVac
@fr